1. News Articles
  2. Related News Articles
News Article Details

NYSE Euronext Units Corpedia and Corporate Board Member Enter Into a Strategic Alliance with Marsh

Source: Marsh

Posted on 22 Mar 2013 by Neilson

Facebook LinkedIn Twitter Google

MarshCorpedia and Corporate Board Member, NYSE Euronext (NYX) companies, and Marsh announced today that they have entered into a strategic alliance to provide directors and officers with enhanced governance, risk and compliance resources.

The alliance combines Corpedia's expertise in governance, risk and compliance education and advisory services, and Corporate Board Member's expertise in providing senior officers and directors with governance and compliance resources, with Marsh's directors and officers liability (D&O) expertise, powerful analytical platform, and claims advocacy support. Together, they will provide directors and officers with unrivaled advisory services and resources they need to make informed decisions on compliance-related trends and issues.

In the first of what will be several new joint offerings, the organizations have launched the Board Compliance Oversight and Governance Diagnostic. The diagnostic assists companies in benchmarking their current board programs to those of their peers and provides insight into ways they can improve governance processes and mitigate risk.

Commenting on the alliance, David Bidmead, U.S. CEO of Marsh said, "One of the greatest risks companies face today is the evolving scope and complexity of regulatory reform, which creates a great degree of uncertainty from a D&O liability standpoint. Through our alliance with Corpedia, we will give companies and their directors and officers the tools they need to better understand the increasingly challenging regulatory framework in which they operate and ensure that they are conversant and compliant."

Corpedia President Tim Erblich stated, "Board members are increasingly aware of and interested in compliance issues as a result of high-profile compliance failures covered regularly in the news and increased interest from regulators, investors, and insurers. We are excited about the prospects of enhancing our board and director advisory services and expanding our benchmarking not only to our network of NYSE Euronext companies, but to any public or private company board that is striving to improve its governance and effectiveness."

For more information about the Board Compliance Oversight and Governance Diagnostic or to request the complimentary diagnostic, go to